APRE
Aprea Therapeutics, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.62
- As of
Share the APRE intelligence card
See APRE live in the terminal
Track APRE's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live APRE terminal, freeActive signals for APRE
- mediumNEW_POSITION
RENAISSANCE TECHNOLOGIES LLC new position in APRE
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 6.2% - EPS $-0.22 vs $-0.2346 estimate
- mediumEARNINGS_BEAT
Q4-2025: Beat consensus by 19.6% - EPS $-0.32 vs $-0.3978 estimate
- mediumEARNINGS_BEAT
Q2-2025: Beat consensus by 30.3% - EPS $-0.53 vs $-0.7599 estimate
- mediumEARNINGS_MISS
Q3-2025: Missed consensus by 36.1% - EPS $-0.47 vs $-0.3453 estimate
Top institutional holders of APRE (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLC | $44K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLC | $19K | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, APRE
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Catch the next move on names like this
New 13F filings, insider trades, and cross asset signals like the ones above, in your inbox each morning or live on Telegram. Free, no account.
One email a day. Unsubscribe anytime. We never sell your data.
See more APRE signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to APREand get the insider, 13F, options, and confluence read in one view.